Sumeet Bhanvadia
@sumeetbhanvadia
urologic cancer surgeon, Sr. Medical Director-Bladder Cancer @JanssenUS, mom, wife, circumstantial vegan, not in that order
ID: 708012438378024960
10-03-2016 19:31:34
148 Tweet
651 Followers
267 Following
#GU21 ASCO Finally the phase 3 data on adjuvant nivolumab in Bladder Cancer Advocacy Network Trial met the primary endpoint of significantly improved disease free survival with OncoAlert Hopefully approval soon @MattGalsky UroToday.com
Well of course!! And — you’re welcome Saum Ghodoussipour and Nima Nassiri, MD
Proud to have worked with several of these USC Urology — congrats to all! Dr Gerhard Fuchs Brian Hu Isuru Jayaratna MD
More data suggesting access and quality supersedes race-based biology in PrCa. cc: Dr. Brandon Mahal Daniel E Spratt Dr. Adam Murphy Association of Health-Care System with Prostate Cancer-Specific Mortality in African American and Non-Hispanic White Men academic.oup.com/jnci/advance-a…
#ASCO21 ASCO Plenary #LBA5 : Keynote-564 trial results just out 👉bit.ly/3g4mQ6Q ,in patients with high risk resected #kidneycancer: Pembrolizumab significantly improves disease free survival. Practice changing data Congrats Toni Choueiri, MD Tom Powles OncoAlert
Great slide Fola May, MD PhD! We must continue to address upstream factors to end disparities in cancer screening and care. #healthequity #ASCO2021 ACS National Colorectal Cancer Roundtable ACSNews
Excited to be part of such an awesome team and doing this important work! USC Urology
🙏🏽 Collaborative work with my alma mater USC Urology reporting on historic and contemporary outcomes after radical cystectomy Sia Daneshmand, M.D. Anne Schuckman Dr. Hooman Djaladat Sumeet Bhanvadia
🚀🦾Huge congratulation to our USC Urology Chair Dr. Inderbir Gill for the Amer. Urol. Assn. Presidential Citation for scientific innovations in robotic and laparoscopic oncologic surgery Amer. Urol. Assn. Journal of Urology @KeckMedUSC European Association of Urology (EAU) AI Center at USC Urology
No small feat to summarize this massive experience in #cystectomy from my colleagues at USC Urology. Terrific work from Sia Daneshmand, M.D.'s group (Anirban Mitra Sumeet Bhanvadia Dr. Hooman Djaladat et al) that underscores need to do more post-cystectomy to prevent relapse (eg #PROOF302, IO)
Committed and persistent work by Anirban Mitra and Sia Daneshmand, M.D. highlighting post-cystectomy outcomes in which we’re improving, but also those that unfortunately have stayed the same. Hopefully can steer and support the need for exciting ongoing research like that of Sumanta K. Pal, MD, FASCO
Thank you UroToday.com for highlighting our work looking at how a navigator can improve 3rd line treatment rates!
SunRISe-1 Sia Daneshmand, M.D. #AUA23 safety efficacy data up to 73% CR up to 11mo for bcg unresponsive nmibc! 💪 exciting results minimal toxicity! 🥨 JNJInnovative Medicine
Breaking news from #AUA23 Amer. Urol. Assn. : Sia Daneshmand, M.D. presents 1st results from SunRISE-1 trial 👉TAR-200 (local gemcitabine delivery system in bladder) in BCG refractory high-risk non-muscle invasive #bladdercancer 👉 amazing ~73% complete response 👇OncoAlert UroToday.com